1 熊红,吴秋业,廖洪利,等.糖基化修饰的树突状细胞疫苗激发的骨髓瘤特异性T细胞免疫反应[J]. 现代免疫学, 2007, 27(1): 53~58. 2 An H J, Froehlich J W, Lebrilla C B. Determination of glycosylation sites and site-specific heterogeneity in glycoproteins[J]. Curr Opin Chem Biol,2009,13(4):421~426. 3 Arnold J N, Wormald M R, Sim R B, et al. The impact of glycosylation on t he biological function and structure of human immunoglobulins[J]. Annu Rev Immunol,2007,25:21~50. 4 Blom N, Sicheritz-Pontén T, Gupta R, et al. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence[J]. Proteomics,2004(4):1633~1649. 5 Burgdorf S, Kautz A, Böhnert V, et al. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation[J]. Science,2007,316(5824):612~616. 6 Elliott S, Lorenzini T, Asher S, et al. Enhancement of therapeutic protein in vivo activities through glycoengineering[J]. Nat Biotechnol,2003,21(4): 414~421. 7 Erbacher A, Gieseke F, Handgretinger R, et al. Dendritic cells: functional aspects of glycosylation and lectins[J]. Hum Immunol,2009,70(5):308~312. 8 Ferrara C, Stuart F, Sondermann P, et al. The carbohydrate at Fcγ RIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms[J].J Biol Chem,2006,281(8):5032~5036. 9 Lam J S, Huang H, Levitz S M. Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells[J]. PLoS One,2007,2(10):e1009. 10 Luong M, Lam J S, Chen J, et al. Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines[J]. Vaccine,2007,25(22):4340~4344. 11 McKenzie E J, Taylor P R, Stillion R J, et al. Mannose receptor expression and function define a new population of murine dendritic cells[J]. J Immunol,2007,178(8):4975~4983. 12 Selman M H, de Jong S E, Soonawala D, et al. Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination[J]. Mol Cell Proteomics,2012,11(4):M111. 13 Solá R J, Griebenow K. Effects of glycosylation on the stability of protein pharmaceuticals[J]. J Pharm Sci,2009,98(4):1223~1245. 14 Solá R J, Griebenow K. Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy[J].Bio Drugs,2010,24(1):9~21. 15 Stowers A W, Chen Lh L H, Zhang Y, et al. A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum[J]. Proc Natl Acad Sci USA,2002,99(1): 339~344. 16 van Vliet S J, García-Vallejo J J, van Kooyk Y. Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses[J]. Immunol Cell Biol,2008,86(7):580~587. 17 Xin H, Dziadek S, Bundle D R.Synthetic glycopeptide vaccines combining β-ma30,6-Djhydroxycholanic Acidan and peptide epitopes induce protection against candidiasis[J]. Proc Natl Acad Sci USA,2008,105(36):13526~13531. 18 Yamada K, Park C H, Noguchi K, et al. Serial passage of a street rabies virus in mouse neuroblastoma cells resulted in attenuation: Potential role of the additional N-glycosylation of a viral glycoprotein in the reduced pathogenicity of street rabies virus[J].Virus Res,2012,165(1):34~45. 19 Zhong W. Golgi during development[J]. Cold Spring Harb Perspect Biol,2011,3(9): a005363. |